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Abstract
Spinal cord injury (SCI) induces both primary uncontrollable mechanical injury and secondary controllable degeneration,
which further results in the activation of cell death cascades that mediate delayed tissue damage. To alleviate its
impairments and seek for an effective remedy, mRNA differential display was used to investigate gene mRNA expression
profiling in mice following SCI. A specific Zinc finger and BTB domain-containing protein, CIBZ, was discovered to implicate
in the SCI process for the first time. Further researches indicated that CIBZ was extensively distributed in various tissues, and
the expression level was highest in muscle, followed by spinal cord, large intestine, kidney, spleen, thymus, lung, cerebrum,
stomach, ovary and heart, respectively. After injury, the CIBZ expression decreased dramatically and reached the lowest level
at 8 h, but it gradually increased to the maximal level at 7 d. Caspase-3 and C-terminal-binding protein (CtBP), two CIBZ-
related proteins, showed similar tendency. Interestingly, p53 expression remained constant in all groups. Via flow cytometry
(FCM) analysis, it was found that the cell death rate in SCI group markedly increased and reached the highest value 1 d after
surgery and the mitochondrial transmembrane potential (DYm) at 1 d was the lowest in all groups. Taken together, it is
suggested that: (i) in the presence of CtBP, CIBZ gene is involved in secondary injury process and trigger the activation of
apoptotic caspase-3 and bax genes independent of p53; (ii) abrupt down-regulation of CtBP at 8 h is a sign of mitochondria
dysfunction and the onset of cell death; (iii) it could be used as an inhibitor or target drug of caspase-3 gene to improve
spinal cord function.
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Introduction
Spinal cord injury (SCI) is always an unsolved human challenge.
More than half of SCI survivors cannot return to their normal life.
Neurological damage after acute SCI results from both primary
mechanical injury and subsequent activation of cell death cascades
mediating delayed tissue damage [1–3]. It is inevitable that the
primary injury results from actual mechanical tissue disruption, as
well as necrotic cell death. It is controllable that the secondary
degeneration results from a cascade of events triggered by the
injury, resulting in activation of endogenous cell death pathways
[4]. Two morphologically distinct pathways, necrosis and
apoptosis, are involved in the secondary process.. The latter is
considered as physiological or programmed cell death and may be
induced by external or internal stimuli [5–9]. The vital role of
caspases in apoptosis is well known. The activation of Caspase-3
family proteins has been well demonstrated in animal models, and
their inhibitors not only reduced tissue damage, but also improved
neurological function [10]. Served as potential target pharmaceu-
ticals, caspase-3 inhibitors have caught the attention of many
scientists for curing apoptosis-related diseases and for alleviating
impairments induced by SCI [11–16]. Many studies have
investigated the changes at the RNA and protein levels after
spinal cord injury and focused only on a few genes of interest
[11,12,14,17,18,19]. It is revealed that administration of Ac-
DMQD-CHO, a caspase-3 inhibitor, can decrease apoptosis and
improve functional outcome in SCI rat model [17]; the broad
specific caspase inhibitor (z-VAD fmk) administrated by a variety
of routes (including local, subarachnoidal, intravenous and
intraperitoneal), following SCI did not improve neurological
deficits and tissue damage, or did not prevent XIAP cleavage
that is associated with apoptotic death following SCI [13]; in
addition, administration of the caspase-3 inhibitor z-DEVD.fmk, a
selective and irreversible caspase-3 inhibitor, helped to limit
secondary damage and provided significant neuroprotection in rat
model [20]. Nimodipine (L-type Ca
2+ channel antagonist), IL-10
and 2, 29-methylenebis can alleviate apoptosis-mediated impair-
ments via mitochondrial pathway after spinal cord injury
[12,21,22]. In summary, it is suggested that agents blocking
apoptotic pathways may be of value for treating SCI in the future.
Nevertheless, the foregoing researchers have not reached an
agreement in SCI drugs investigation, and the effective materials
mentioned above are far away from clinical application practically
because none of them is originally screened from SCI animal
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cord after injury is essential to identify ways to limit secondary
damage, topromote axonalregeneration, and ultimatelyto improve
functional outcome [23]. For this purpose, we applied mRNA
differential display to screen candidate genes related to SCI process
from the pool of gene expression profiles. It is discovered that a
novel murine BTB domain-containing protein, CIBZ, is involved in
spinal cord injury via mitochondrial pathway in mouse model.
Materials and Methods
Materials and Grouping
36 mice purchased from Nanjing Qinglongshan Experimental
Animal Factory, were reared in separate cages in accordance with
the National Institutes of Health guidelines including free diet, 12–
12 h light-dark cycles and optimal room temperature [21]. 25–
30 g mice were randomly divided into 6 groups (6 mice in each
group: 3=&3 R): control group underwent sham injuries in which
only vertebral plates were cut off without causing any spinal
injuries, and the 4 h, 8 h, 1 d, 3 d and 7 d group underwent SCI.
Animal Model Establishment
In this study, the improved SCI mouse model were established
[21]. Animals were anesthetized with chloral hydrate (4 mg/kg,
IP). The spinal processes from Th7 to Th9 were exposed in all
groups. Mice in 4 h, 8 h, 1 d, 3 d and 7 d SCI groups underwent
a 30 g weight drop pressed against the spinal cord for five minutes
(30 g65 min). Successful SCI was confirmed by quick jerks of the
hind limbs observed in trauma-surgery animals. All groups were
reared under optimal environmental conditions after operation.
mRNA differential display and SCI-associated gene
screening
Mice were euthanized by cervical vertebra dislocation at 4 h, 8 h,
1 d, 3 d and 7 d after SCI, and spinal cord samples were collected.
The spinal cords of control group were also sampled at 3 d after sham
injuries. Trizol reagent (Invitrogen Co. Ltd.) was used to extract total
RNA from the above samples. RT reactions were carried out
according to protocol of the kit (Promega Co. Ltd.). Primers
combinations between 20 random and 3 anchor primers (2063
combinations) were used to amplify cDNA samples in the subsequent
RT-PCR reactions, and the primer sequences were listed in Table 1
and 2. The PCR products were separated by electrophoresis on 12%
polyacrylamide gels (16TBE buffer, 180 V, 5 h) and stained with
AgNO3. The differentially expressed fragments were extracted and
reamplified by nested PCR, then the products were purified with gel
purification kit, cloned into the vector pMD-18T and transformed
into E Coli DH-5a. Positive clones were sequenced in both directions
using an ABI Prism
TM 377 (GenScript Corporation, Nanjing, China).
The sequences were aligned withB L A S Ti nN C B Ia n dC o n t i gm a p
a n a l y s i so nt h ec h r o m o s o m et od e c i d ew h a tk i n do fg e n ew o u l db e .
The differentially expressed bands in the products amplified with
primer combination between primer 11 and anchor primer 6 were
selected for further research.
CIBZ mRNA expression in various tissues by RT-PCR
Total RNA was extracted from various tissues (including kidney,
stomach, thymus, large intestine, lung, spinal cord, spleen, heart,
muscle, ovary and cerebrum etc.). RT-PCR was processed
according to section 1.3. A pair of primers was redesigned to
amplify CIBZ gene (listed in Tab.3). A pair of primers (upstream:
59-GCAATGCCTGGGTACATGGTGG-39; downstream: 59-
GTCGTACCACAGGCATTGTGATGG-39) was used to ampli-
fy the b-actin gene as an internal standard. PCR products were
separated on 2% agarose gel and stained with ethidium bromide.
To confirm the identity of PCR products, single bands of the
expected size were excised from the gels and sequenced. The
CIBZ gene expression levels in different tissues were calculated
with BandScan v5.0 software.
CIBZ expression and distribution
CIBZ was also detected immunohistochemically in the spinal
cord after injury. CIBZ antibodies (NBP1-18299, Novus Biologicals
Co. Ltd., USA) were diluted in antibody diluent according to ABC
kits (Boster, Wuhan, China) in advance. Th7–Th9 tissue samples
fixed in phosphate-buffered 10% formalin and embedded in
paraffin wax were serially sectioned (5 mm), and mounted on
APES-coated slides (Boster, Wuhan, China). These slides were
dewaxed, washed incitratebuffer (pH 6.0;10 min), blocked in 10%
normal goat serum/4% BSA (overnight at 4uC) and then incubated
(1 h at room temperature) with CIBZ antibody. After rinsing in
0.05 ml PBS, sections were incubated for 1 h in biotinylated sheep
anti-mouse IgG antibodies diluted 1:500 antibody diluent. After
washing with PBS and subsequent incubation for 1 h, the
Streptavidin peroxidase complex was applied. After washing again,
the peroxidase reaction was carried out in DAB solution containing
Table 1. Sequences of random primers.
Labeling of random primer Primer sequence
1 ACCGCGAAGG
2 GGACCCAACC
3 GTCGCCGTCA
4 TCTGGTGAGG
5 TGAGCGGACA
6 ACCTGAACGG
7 TTGGCACGGG
8 GTGTGCCCCA
9 CTCTGGAGAC
10 GGTCTACACC
11 AGCGCCATTG
12 CACCGTATCC
13 GGGGTGACGA
14 CTTCCCCAAG
15 CATCCGTGCT
16 AGGGCGTAAG
17 TTTCCCACGG
18 GAGAGCCAAC
19 GAGAGCCAAC
20 ACCCGGTCAC
doi:10.1371/journal.pone.0033156.t001
Table 2. Anchorage primer sequences.
Labeling of anchorage primer Primer sequence
H-T11G (anchorage4) AAGCTTTTTTTTTTTG
H-T11C (anchorage 5) AAGCTTTTTTTTTTTC
H-T11A (anchorage 6) AAGCTTTTTTTTTTTA
doi:10.1371/journal.pone.0033156.t002
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washed with distilled water again. After light counterstaining with
Mayer’s hematoxylin, the sections were dehydrated and covered
with cover slip. Photomicrographs were taken with a Leica DM
2500 microscope. The dark-brown positive cells in sections were
counted using 106ocular and 406objective (4006). The average
numberofpositivecellsfrom 20randomly-selectedfields ofdifferent
groups were determined and used in data analysis. The integrate
optic densities (IOD) of CIBZ immune positive (IR) neural fibers
and neurons were analyzed by Image-Pro Plus 6.0 (IPP6.0).
CIBZ expression after SCI injury by Western-blot analysis
Spinal segments Th7–Th9 were collected from animals in all
g r o u p sa n dd i g e s t e db y0 . 2 5 %t r y p s i n – 0 . 0 2 %E D T A( G i b c o
Laboratories, USA). After suspension, the dissociated cells were
rinsed with PBS and filtered with nylon net (400 holes). Cells
suspension (3610
6 for each sample) (from 1.3) was centrifuged at
3000 rpm for 5 min at 4uC, then the Cells precipitation was washed
with PBS and suspended in extraction buffer and lysis solution. For
analysis of CIBZ, 25 mg extracted proteins were separated on a 12%
SDS-PAGE denaturing gel and transferred to nitrocellulose mem-
brane (Amersham BioSciences, Piscataway, NJ). Equivalent loading
was checked by actin staining. Membranes were blocked in 5% milk
then probed with CIBZ antibodies (1:200). Expression of proteins was
quantified by density analysis using BandScan v5.0 software.
CIBZ-pathway associated gene expression by relative
RT-PCR
The cDNA samples collected at different phases were used to
analyze the CIBZ-pathway associated gene expression level. With
b-actin being an internal standard, p53, caspase-3, CIBZ and
CtBP gene expression were studied using semi-quantitative RT-
PCR. The primers were designed and confirmed to be unique in
the nonredundant NCBI Database and were listed in Table 3.
CIBZ and b-actin primer sequences were the same as before. The
reaction products and their intensities in RT-PCR were quantified
densitometrically and normalized for the expression of the b-actin
gene using BandScan v5.0 software.
The cell death rate in the spinal cord was analyzed by
flow cytometry after SCI injury
Cells from animals in all groups were diluted into (1–5)610
6
cell/ml, fixed with 70% ethanol (4uC) for 1–2 h and rinsed with
PBS (5 min63). The cells were analyzed with flow cytometry
(Becton Dickinson) after being stained with 1 ml propidium iodide
(including RNAase) for 30 min. The wavelength of laser was
488 nm and the wavelength of emitted light was above 630 nm.
The histogram was used to assay the red intensity of propidium
iodide. The software Cell Quest and Modfit LF were used to assay
the cell death rate of 10000 cells. The number of cell death was
counted and expressed with blue wave peak [21].
Measurement of mitochondrial transmembrane potential
(DYm) of sipial cord cells by flow cytometry
Flow cytometric analysis of mitochondrial activity was deter-
mined by using rhodamine 123 (Rh123). Loss of mitochondrial
transmembrane potential (DYm) results in diminished cell ability to
accumulate fluorochrome Rh123. The suspended spinal cord cells
were then incubated with 10 mg/ml Rh123 at 37uC for 30 min,
digested by 0.25% trypsin-0.02% EDTA and washed with ice-cold
PBS. Finally, the cells were washed and re-suspended in 0.5 ml PBS
before fluorescence was measured using flow cytometry [21].
Statistic Analysis
The data were expressed as mean 6 SD and analyzed using
one-way ANOVA (SPSS 17.0 software package). LSD-t test was
used for multiple comparison to identify differences between
groups of 5% and 1% significance level. Original data were Z-
score transformed as needed to ensure homogeneity of variance.
Results
CIBZ was detected in mRNA differential display analysis
A 430 bp differential expression band amplified with combina-
tion between primer 11 and anchor primer 6 was detected in
expression profiles (black arrow, Figure 1). The band was excised,
extracted and amplified with nested PCR (Figure S1a). The PCR
product was sequenced (Figure S1b).
The sequence was aligned with BLASTin NCBI (FigureS2a), and
the sequence analysis of the cDNA revealed that it is 99%
homologous to mouse 16274888–16275218 bp sequence on the 9
th
chromosome. BLAST hits indicated that it was exactly located at the
16257627–16303924 bpsites of ref|NT_039476.7|Mm9_39516_37
on the 9
th chromosome. The differential expression fragment
belonged to 59-UTR of mouse CIBZ (ZBTB38) gene through
Contig map analysis on the chromosome (Figure S2b).
CIBZ mRNA expression in various tissues in vivo
The size of amplified CIBZ fragments was the same as expected
(500 bp). CIBZ gene is extensively distributed in various tissues
and no tissue-specific expression was observed. The expression
level was highest in muscle, followed by spinal cord, large intestine,
kidney, spleen, thymus, lung, cerebrum, stomach, ovary and heart
etc, respectivley (Figure 2).
Table 3. Targe genes, GenBank accessions, primer sequences, predicted size of PCR products and annealing temperatures in RT-
PCR analysis.
Target gene GenBank accession Primer sequence Size of predicted product Annealing temperature
CIBZ NT-039476 Upstream: 59-GCTCGTGCTTCTGTAGGTTC-39
Downstream:59-GCTTTGCCAGGCTGAATGTGT-3
500 bp 55.9uC
caspase-3 NM-009810 Upstream: 59-AGCTTCTTCAGAGGCGACTA-39
Downstream:59-GGACACAATACACGGGATCT-39
381 bp 58.5uC
CtBP NC-000081 Upstream: 59- ACAGGTACAGCACAGGCA -39
Downstream: 59- TGCTGAACAGAGAAAGGA -39
630 bp 56.7uC
p53 NT-033777 Upstream: 59- ACTGCATGGACGATCTGTTG -39
Downstream:59-GCCATAGTTGCCCTGGTAAG -39
495 bp 58.8uC
doi:10.1371/journal.pone.0033156.t003
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neurons after SCI injury
Immunohistochemical staining identified that the cytoplasm of
all positive cells were stained in yellow-brown; positive cells were
observed in both gray and white matter; staining in the white
matter was much more intense than that in other regions
(Figure 3a); In addition, the IOD of CIBZ-IR neural fibers and
neurons in control group decreased immediately after SCI injury,
then reached the lowest (56.766.8) level at 8 h. However, it
dramatically increased and reached the highest level (457.2625.6)
at 7 d after injury (Figure 3c). Statistical analysis revealed that
there was significant difference in the IOD levels between the
sham-operated control groups and SCI groups (P,0.01). In the
7 d group, it was also found that the spinal cord presented
vacuolization, neurons decreased and glial cells teemed (Figure 3a).
CIBZ protein level following injury
CIBZ level of spinal cord decreased accordingly after SCI
injury, It reached the lowest level at 8 h, and then upregulated and
reached the highest at 7 d following injury (Figure 3b, 3d). The
CIBZ variation almost had the same tendency as IOD change.
CIBZ, caspase-3, CtBP and p53 gene expression in spinal
cord of different groups
4–8 h after injury, CIBZ gene expression declined drastically to
between 20–50%,,then gradually increased from 8 h to 7 d
(Figure 4a, 4b). CIBZ expression was lowest at 8 h, but it
rebounded to the peak at 7 d. And there was significant difference
between the levels at 4 h, 8 h, 1 d, 3 d, 7 d and the control groups
after injury (P,0.05). Caspase-3 gene also decreased from 4 h to
8 h after injury, then increased from 1 d to 7 d. Caspase-3
expression was the highest at 3 d, and there was significant
difference between the levels at 1 d, 3 d, 7 d and the control
groups after injury (P,0.01). CtBP expression suddenly decreased
at 4 h, then restored to normal level, and there was significant
difference between the levels for the control, 8 h, 1 d, 3 d, 7 d and
4 h groups after injury (P,0.01). Interestingly, p53 expression
remained constant in all groups (Figure 4a, 4b).
The changes of cell death rate after SCI
The cell death rate (Figure 5a) in SCI group increased
profoundly from 0.34% at 4 h to 30.24% at 8 h, and rapidly
reached the highest (48.73%) at 1 d after surgery (Figure 5b), but it
decreased to 28.74% at 3 d and 27.02% at 7 d. It is significantly
different from the control and 4 h groups (Figure 5b) (P,0.01).
Mitochondrial membrane potential (DYm) changes of
spinal cord cells after SCI
The mitochondrial transmembrane potential decreased immedi-
ately and reached its lowest value at 1 d after SCI, and it was
significantly different from the control group (P,0.01). DYm
gradually increased from 1 d to 7 d afterwards (Figure 6a, 6b).
The cellular ability to uptake Rh123 underwent dramatic reduction
after SCI.
Discussion
CIBZ is involved in SCI process independent of p53 gene
For the first time, we found that CIBZ gene was involved in SCI
process in vivo in the present study. CIBZ (ZBTB38 in human) is one
of the members of BTB domain-containing protein family
containing Kaiso-like zinc finger, however, little is known about
its physiological function [24,25]. CIBZ interacts with CtBP and
binds methylated DNA, so it belongs to a novel class of methylated
DNA-binding proteins [26,27,28]. It was reported that CIBZ was
highly expressed in proliferating C2C12 cells but its expression
levels decreased upon induction of apoptosis by serum starvation.
Knockdown of CIBZ in C2C12 cells induced apoptosis, activation
of caspase-3, 7, 9, and cleavage of poly (ADP-ribose) polymerase
[18,27,28,29]. It is suggested that CIBZ-associated apoptosis occurs
throughthemitochondrial pathway in vitro.CIBZ
2/2p53
2/2mouse
embryonic fibroblast cells also activated caspase-3 [26,27]. It can be
inferred that CIBZ-associated apoptosis is mediated by a p53-
independent pathway in vitro.
However, the foregoing studies were based on the evidences in
vitro. In this study, it was found that CIBZ declined after injury,
then increased suddenly from 1 d. It was previously reported that
the proportion of early apoptotic cells and late cell death increased
significantly to their maximum levels from 1 d to 3 d after SCI via
FCM analysis [21,30]. Nevertheless, the minimum value of CIBZ
expression occurred at 8 h. It was also puzzling that caspase-3
gene expression was not contrary to CIBZ expression as expected.
The conditions in vivo are completely different from those in vitro,s o
we suggest that injury-induced down-regulated CIBZ expression is
an early event in vivo, while apoptosis and caspase-3 family
Figure 1. mRNA profiles of different groups upon DDRT-PCR.
Black arrow: A differential expression band in this study amplified with
primer 11 and anchorage 6. Different lanes respectively represented:
control, 4 h, 8 h, 1 d, 3 d and 7 d groups.
doi:10.1371/journal.pone.0033156.g001
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different tissues, especially in spinal cord.
doi:10.1371/journal.pone.0033156.g002
Figure 3. CIBZ protein expression level in the spinal cord after SCI injury. a: CIBZ immunohistochemistry staining in spinal cord after SCI
injury. 1A, 1B: control group; 2A, 2B: 4 h group; 3A, 3B: 8 h group; 4A, 4B: 1 d group; 5A,5B: 3 d group; 6A, 6B: 7 d group. Positive cells were observed
in both gray and white matter, and the staining in the white matter was much more intense than those in other regions. c: Statistic analysis of CIBZ-IR
IOD. CIBZ-IR IOD decreased at first and up-regulated later, the inflection point was at 8 h. Data are expressed as mean6SD. *, P,0.05; **, P,0.01;
N=6. b: CIBZ expression after SCI injury subjected to Western-blot analysis. The immunoblot result indicated that CIBZ level increased slightly at 4 h,
declined sharply at 8 h and gradually increased from 1 d to 7 d. d: Statistic analysis of CIBZ protein level. Data are expressed as mean6SD. *, P,0.05;
**, P,0.01; N=6.
doi:10.1371/journal.pone.0033156.g003
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unchanged p53 expression, we could deduce that CIBZ gene
was also involved in SCI independent of p53 in vivo.
CIBZ expression increased from 1 d to 7 d, suggesting that
spinal shock induced compensatory mechanism in improving the
CIBZ expression for self-healing. Hence, it is beneficial and
effective for animal recovery at later stage as high level CIBZ can
suppress ill effects induced by high level of caspase-3. In previous
studies, it was found that c-kit gene up-regulated and reached peak
value from 8 h to 7 d. As a marker of stem cell, its up-regulation
signified the activation of stem cells and rehabilitation improve-
ment [30,31,32]. Whether the two factors cooperate and promote
the process needs our further investigation on the underlying
sense.
Figure 4. Analysis of CIBZ, caspase-3, CtBP and p53 mRNA level by semi-quantitative RT-PCR. a: The expression level of target gene
mRNA analyzed by semi-quantitative RT-PCR. b: Statistic analysis of CIBZ, caspase-3, CtBP and p53 mRNA level. CIBZ and caspase-3 reached the
lowest level at 8 h, but CtBP at 4 h. p53 remains constant in all groups. Data are expressed as mean6SD. *, P,0.05; **, P,0.01; N=6.
doi:10.1371/journal.pone.0033156.g004
CIBZ Is Involved in Mouse Spinal Cord Injury
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33156In conclusion, as a reported negative regulator of apoptosis
induced by capase-3 mitochondrial pathway in murine cells [27] in
vitro and a promising SCI medication, CIBZ potentially alleviates
secondary injury in vivo. Providing CIBZ is medicated in early injury
period (4 h–8 h) or used genetically through CIBZ modified neural
stem cells (NSCs) [33], it would deter the cell death-induced
impairments. Further researches are needed to explore this possibility.
Sudden CtBP down-regulation at 8 h is a sign of
mitochondria dysfunction and the onset of cell death
CtBP expression drastically declined to a minimum at 4 h, then
restored to the normal level. It is reported that CtBP-knockout
cells were hypersensitive to apoptosis. CtBP-rescued mouse
embryo fibroblasts revealed that CtBP regulates many pro-
apoptotic genes and modulates the cellular threshold for apoptotic
responses. CtBP can repress Bcl-2-associated X protein (Bax)
transcription [34]. CtBP knockout increases Bax transcription,
ablates mitochondrial morphology and reduces mitochondrial
activities. Ectopic expression of CtBP or knockdown of Bax in
CtBP-knockout cells recovers mitochondrial morphology and
function, suggesting that CtBP functions as a metabolic sensor
that maintains mitochondrial activities in vitro [35]. In previous
studies, it was found that bax regulation from 4 h and injury-
induced mitochondria dysfunction after SCI [30,31,32]. In this
study, the mitochondrial transmembrane potential reduced to the
lowest level at 24 h. It can be inferred that sudden CtBP down-
regulation at early stage is also a prelude of mitochondria
dysfunction and onset of cell death in vivo.
Besides, Several reports linking CtBP with p53-independent cell
death in vitro [27,36,37] : (i) targeting of CtBP by ARF (alternate
open reading frame) results in p53-independent apoptosis; (ii)
HIPK2 (homeodomain interacting protein kinase 2) mediates CtBP
Figure 5. The cell death rate in all groups by FCM analysis. a: FCM analysis of all groups. b: Statistic analysis of cell death rate. The data
indicated that the rate ascended rapidly after 4 h post injury, arrived at the highest level at 1 d and decreased subsequently and remained about 30%
level. Data are expressed as mean6SD. *, P,0.05; **, P,0.01; N=6.
doi:10.1371/journal.pone.0033156.g005
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triggered active JNK1 (c-Jun N-terminal kinase 1) promotes
apoptosis by phosphorylated and down-regulated CtBP in human
lung cancer cells. These findings demonstrated that CtBP protein
plays important roles in regulating p53-independent programmed
cell death, although the precise mechanism and signaling pathway
remain unclear. In the present study, unchanged p53 expression
and CtBP down-regulation do indicate that CtBP is involved in
spinal cord injury independent of p53 in vivo.
In summary, in the presence of CtBP, CIBZ gene is involved in
secondary injury process. CIBZ possibly triggers the activation of
apoptotic caspase-3 and bax genes independent of p53, and cell
death-induced jury burst. It is suggested that CIBZ is able to be
used as an inhibitor or target drug of caspase-3 gene in improving
spinal cord function.
Supporting Information
Figure S1 Identification of CIBZ gene. S1a: The differential
expression fragment (black arrow) was re-amplified with nested
PCR. The size of PCR products was 430 bp. S1b: Sequencing
wave of CIBZ gene. Sequencing result of differential expression
fragment was also shown.
(TIF)
Figure S2 The analysis of differential expression frag-
ment. S2a: Differential expression sequence was aligned with
BLAST in NCBI. It is 99% homologous to mouse 16274888–
16275218 bp sequence on the mouse 9th chromosome. S2b:
Contig map analysis indicated that it belongs to 59-UTR of CIBZ
gene.
(TIF)
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